Adolescent and young adult patients who select long-acting reversible contraception (LARC) attend fewer well-woman visits and have reduced testing for sexually transmitted infections (STIs), new research shows.
LARC Use Can Affect Well-Woman Visits and STI Screening
October 1, 2024